dr. Bert Vander Cruyssen
No current affiliation with UGent
Show
Sort by
-
Etanercept in patients with inflammatory hand osteoarthritis (EHOA) : a multicentre, randomised, double-blind, placebo-controlled trial
-
- Journal Article
- A1
- open access
Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitis
-
Predictors of functional impairment and pain in erosive osteoarthritis of the interphalangeal joints: comparison with controlled inflammatory arthritis
-
- Journal Article
- A1
- open access
Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints : a double blind, randomised trial on structure modification
-
- Conference Paper
- C3
- open access
Use of fecal calprotectin as marker of disease activity in patients under maintenance treatment with infliximab for ulcerative colitis
-
Predicting the outcome of ankylosing spondylitis therapy
-
Microscopic polyangiitis involving the breast
-
Optimized alkylated cyclodextrin polysulphates with reduced risks on thromboembolic accidents improve osteoarthritic chondrocyte metabolism
-
Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery
-
Health status and impact of pain : a comparative study between female patients with the Ehlers-Danlos syndrome, fibromyalgia and rheumatoid arthritis
-
- Journal Article
- A1
- open access
Seven-year follow-up of infliximab therapy in rheumatoid arthritis patients with severe long-standing refractory disease : attrition rate and evolution of disease activity
-
- Journal Article
- A1
- open access
The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry: clues for the optimization of rituximab treatment strategies
-
Reduced levels of the TGFB family member GDF15 in spondyloarthritis versus other rheumatic diseases
-
- Journal Article
- A1
- open access
Evidence for significant overlap between common risk variants for Crohn's disease and ankylosing spondylitis
-
- Journal Article
- A1
- open access
Morbid anatomy of 'erosive osteoarthritis' of the interphalangeal finger joints : an optimised scoring system to monitor disease progression in affected joints
-
Validation of a new screening strategy for anti-extractable nuclear antigen antibodies
-
Evidence for significant overlap between common risk variants for Crohn's disease and ankylosing spondylitis
-
Cross-cultural adaptation of the Dutch version of the functional index for hand osteoarthritis (FIHOA)and a study on its construct validity
-
Spinal radiographic changes in ankylosing spondylitis: association with clinical characteristics and functional outcome
-
Classification models for disease: the effect of associations between markers on calculating the risk for disease by likelihood ratio products
-
Reversible changes in serum immunoglobulin galactosylation during the immune response and treatment of inflammatory autoimmune arthritis
-
Clinical Observations programme in SpA: disease parameters, treatment options and practical management issues
-
- Conference Paper
- C3
- open access
Reduced metallothionein expression in colonic Crohn's disease: evidence for a new disease-modifying gene
-
Over-representation of construction-related occupations in male patients with systemic sclerosis
-
Xylosan polysulphate as a symptom modifying osteoarthritis drug in patients with finger joint arthritis
-
Epidemiology of hip involvement in ankylosing spondylitis
-
Tapering infliximab dosages after temporary dose increase does not affect treatment survival in an established RA population
-
Spontaneous amelioration in early RA: Role of antibody profiles in predicting decrease of disease activity
-
Prediction models for disease: The effect of associations between markers on calculating the risk for disease by likelihood ratio products in SpA
-
Tapering infliximab dosages after temporary dose increase does not affect treatment survival in an established RA population
-
Validation of a new screening strategy for anti-ENA antibodies
-
Do all anti-citrullinated protein/peptide antibody tests measure the same? Evaluation of discrepancy between anti-citrullinated protein/peptide antibody tests in patients with and without rheumatoid arthritis
-
Cyclodextrin polysulphate protects articular cartilage in experimental lapine knee osteoarthritis
-
Reduced metallothionein expression in colonic Crohn's disease: evidence for it new disease-modifying gene
-
A plant-derived ligand favoring monomeric glucocorticoid receptor conformation with impaired transactivation potential attenuates collagen-induced arthritis
-
Clinical and genetic factors associated with sacroiliitis in Crohn's disease
-
Polymorphisms in the ficolin 1 gene (FCN1) are associated with susceptibility to the development of rheumatoid arthritis and may have an added value in prediction models
-
- Journal Article
- A1
- open access
Polymorphisms in the ficolin 1 gene (FCN1) are associated with susceptibility to the development of rheumatoid arthritis
-
The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice
-
A single early activation of invariant NK T cells confers long-term protection against collagen-induced arthritis in a ligand-specific manner
-
Osteochondral repair in synovial joints
-
The diagnostic value of the anti-human citrullinated fibrinogen antibodies by elisa compared to anti-CCP2 antibodies, and their agreement with ACPA detected by 3 other substrates
-
Clinical assessment in the spondyloarthropathies, including psoriatic arthritis
-
Radiological sacroiliitis in Crohn's disease: A multicenter association study
-
Which patients with ankylosing spondylitis start anti-TNF-alpha therapy in daily clinical practice?
-
Four year follow-up of infliximab in rheumatoid arthritis patients refractory to multiple dmard treatment: Long-term clinical effect and prediction of attrition
-
Modeling the probability for rheumatoid arthritis during diagnostic work-up: How to combine the results of ACPA, RF and HLA-SE testing?
-
Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activity
-
Prediction of dose escalation for rheumatoid arthritis patients under infliximab treatment
-
Polymorphisms in the ficolin 1 gene (Fcn1) are associated with susceptibility to the development of rheumatoid arthritis
-
Comparison of the anti-human citrullinated fibrinogen antibodies assayed by ELISA with 2 other ACPA assays: Diagnostic value and agreement between assays
-
Diagnostic value of anti-human citrullinated fibrinogen ELISA and comparison with four other anti-citrullinated protein assays
-
- PhD Thesis
- open access
Markers and outcome measures in chronic immune mediated artrhritis: from association studies to prediction models.
(2006) -
Altered gut transcriptome in spondyloarthropathy
-
Comparing statistics with machine learning models to predict dose increase of infliximab for rheumatoid arthritis patients
-
- Journal Article
- A1
- open access
CARD15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn's disease
-
A plant-derived compound with fully dissociated properties on glucocorticoid receptor-mediated gene regulation
-
Potent anti-inflammatory, fully dissociative compound for glucocorticoid receptor-mediated gene regulation
-
Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritis
-
Das28 correlates best with the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients
-
Anti-citrullinated protein/peptide antibodies (ACPA) in rheumatoid arthritis: Specificity and relation with rheumatoid factor
-
Mannose-binding lectin (Mbl2) polymorphisms in rheumatoid arthritis are not associated with susceptibility, radiological progression rate, or serological markers
-
DAS28 is a robust measure of the physician's clinical judgment of response infliximab therapy
-
Feature selection in the prediction of Infliximab dose increase
-
Comparison of Machine Learning models for prediction of dose increase in patients with rheumatoid arthritis
-
- Journal Article
- A1
- open access
DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment
-
CARD15 polymorphisms are associated with anti-Saccharomyces cerevisiae antibodies in caucasian Crohn's disease patients
-
Radiological sacroiliitis is linked with CARD15 gene polymorphisms in patients with Crohn's disease
-
The presence of CARD15 polymorphisms is linked with higher ASCA titers in Crohn's disease
-
- Journal Article
- A1
- open access
Radiological sacroiliitis, a hallmark of spondylitis, is linked with CARD15 gene polymorphisms in patients with Crohn's disease
-
Crohn's disease patients with CARD15 variants have higher risk of developing axial joint involvement